Efficacy of Ustekinumab for Active Perianal Fistulizing Crohn Disease: A Double-Center Cohort Study
Mohamed Attauabi, Johan Burisch, Jakob Benedict Seidelin
Abstract
This double-center cohort study found a high short-term and long-term efficacy of ustekinumab for perianal fistulizing Crohn disease that was also well tolerated.
Topics & Concepts
UstekinumabMedicineCrohn's diseaseCohortCohort studyInternal medicineDermatologyGastroenterologyDiseaseAdalimumabInflammatory Bowel DiseaseAutoimmune and Inflammatory DisordersDiverticular Disease and Complications